Additional file 1

advertisement
Skip to main content
Advertisement
Menu
Search
Search
Publisher main menu




Journals
Submissions
Publishing services
About
My Account
Follow BioMed Central


Twitter
Facebook
Journal of Hematology & Oncology
Journal of Hematology & Oncology main menu



Home
About
Articles
Articles


Recent
Most accessed
Recent articles
Recent articles RSS
1. Research
Cancer-associated fibroblasts promote the progression of endometrial
cancer via the SDF-1/CXCR4 axis
Fei Teng, Wen-Yan Tian, Ying-Mei Wang, Yan-Fang Zhang, Fei Guo, Jing Zhao, Chao
Gao and Feng-Xia Xue
Published on: 6 February 2016
2. Research
Haplo-insufficiency of both BubR1 and SGO1 accelerates cellular
senescence
Sung-Hyun Park, Steve Xie, Chinthalapally V. Rao and Wei Dai
Published on: 4 February 2016
3. Research
Autologous cytokine-induced killer cell transfusion increases overall
survival in advanced pancreatic cancer
Zibing Wang, Yuqing Liu, Rui’e Li, Yiman Shang, Yong Zhang, Lingdi Zhao, Wei Li,
Yonghao Yang, Xiaojie Zhang, Tiejun Yang, Changfu Nie, Feng Han, Ying Liu, Suxia
Luo, Quanli Gao and Yongping Song
Published on: 3 February 2016
4. Research
GEP analysis validates high risk MDS and acute myeloid leukemia post
MDS mice models and highlights novel dysregulated pathways
Laura Guerenne, Stéphanie Beurlet, Mohamed Said, Petra Gorombei, Carole Le Pogam,
Fabien Guidez, Pierre de la Grange, Nader Omidvar, Valérie Vanneaux, Ken Mills,
Ghulam J Mufti, Laure Sarda-Mantel, Maria Elena Noguera, Marika Pla, Pierre Fenaux,
Rose Ann Padua…
Published on: 27 January 2016
5. Research
An engineered multicomponent bone marrow niche for the recapitulation
of hematopoiesis at ectopic transplantation sites
Mónica S. Ventura Ferreira, Christian Bergmann, Isabelle Bodensiek, Kristina Peukert,
Jessica Abert, Rafael Kramann, Paul Kachel, Björn Rath, Stephan Rütten, Ruth Knuchel,
Benjamin L. Ebert, Horst Fischer, Tim H. Brümmendorf and Rebekka K. Schneider
Published on: 25 January 2016
View all articles
Most accessed articles
Most accessed articles RSS
1. Review
Mast cell activation disease: a concise practical guide for diagnostic
workup and therapeutic options
Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin
Published on: 22 March 2011
2. Review
Ibrutinib and novel BTK inhibitors in clinical development
Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song and Delong Liu
Published on: 19 August 2013
3. Review
The effects of β-glucan on human immune and cancer cells
Godfrey Chi-Fung Chan, Wing Keung Chan and Daniel Man-Yuen Sze
Published on: 10 June 2009
4. Review
Targeting mitochondrial reactive oxygen species as novel therapy for
inflammatory diseases and cancers
Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang and Xiao-feng Yang
Published on: 25 February 2013
5. Research Article
TMEM140 is associated with the prognosis of glioma by promoting cell
viability and invasion
Bin Li, Ming-Zhu Huang, Xiao-Qiang Wang, Bang-Bao Tao, Jun Zhong, Xu-Hui Wang,
Wen-Chuan Zhang and Shi-Ting Li
Published on: 22 July 2015
View all articles
Aims and scope
Journal of Hematology & Oncology is an open access, peer-reviewed online journal that
encompasses all aspects of hematology and oncology.
Editor's quote
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading
title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The
journal also publishes reviews and research highlights from leading experts in the field. Research
is shared with fast turnaround times in an open access format among laboratory scientists,
physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology
Research highlights
Journal of Hematology & Oncology is now publishing Research Highlights, commentaries on
recently published work that place the new research in the context of the current literature.
Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor
positive advanced breast cancer
Janice Lu
AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-
mediated immunotherapy
Jingjing Wu, Jiaping Fu, Mingzhi Zhang, Delong Liu
Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in secondline setting—its impact on clinical practice
Gaurav Goel, Weijing Sun
Submit a manuscript





Submission Guidelines
Editorial Board
Impact Factor: 4.81
Journal of Hematology & Oncology is the official journal of the Chinese American
Hematologist and Oncologist Network
Read More

Sign up to article alerts
ISSN:
1756-8722
Advertisement






Contact us
Jobs
Manage manuscripts
Sign up for article alerts
Manage article alerts
Leave feedback


Press center
Read more on our blogs






Policies
Licensing
Terms and conditions
Privacy statement
Accessibility
Cookies
Follow BioMed Central

Twitter






Facebook
Google Plus
YouTube
LinkedIn
Reddit
Weibo
© 2016 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.
By continuing to use this website, you agree to our Terms and Conditions, Privacy statement and
Cookies policy.
Download